News

Article

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter, October 2021
Volume16
Issue 10

Gyros Protein Technologies Announces New Titer Kit

Gyros’ new titer kit identifies adeno-associated virus serotype 9 in vector-based cell and gene therapy manufacturing.

Gyros Protein Technologies, a peptide synthesizers and reagents provider, introduced the GyrolLab AAv9 Titer Kit on Sept. 30, 2021. The Gyrolab is designed for rapid determination of physical titer in adeno-associated virus serotype 9 (AAV9) vector-based cell and gene therapy manufacturing.

The Gyrolab is based on a highly selective AAV9 affinity ligand. The company indicated that the AAV9 serotype was used as a gene delivery vector because of its ability to cross the blood-brain barrier and target the central nervous system with high efficiency.

Gyros claims that the Gyrolab has an improved assay working range compared to enzyme-linked immunoassay (ELISA) methods and can generate 96 data points in 80 minutes. Additionally, the company states that it can handle 10x smaller sample volumes relative to ELISA methods.

“The addition of Gyrolab AAV9 Titer Kit to our portfolio of ready-to-use kits exemplifies our commitment to offering the whole range of tools required for analytical characterization during manufacturing and purification of cell and gene therapies,” said Mark Vossenaar, vice-president and general manager of Gyros Protein Technologies, in the press release. “Physical titer determination is one of the key quality attributes of the FDA process validation guidelines and our new kit will enable researchers to maximize performance and productivity when developing therapies based on the AAV9 serotype, which will ultimately reduce the time needed to produce patient treatments.”

Source: Gyros Protein Technologies

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content